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1. Introduction
  Despite the remarkable progress made in preventing 
mother to child HIV transmission (PMTCT), particularly in 
sub-Saharan Africa, the transmission continues to occur 
during pregnancy, labor, delivery and breastfeeding. 
  In industrialized nations, the development of effective 
strategies against HIV/AIDS has reduced the risk of HIV 
transmission from mother to child to less than 2%. In the 
absence of adequate prevention of HIV positive pregnant 
women with antiretroviral treatment, the rate of HIV 
transmission from mother to child is about 15%-20%[1]. The 
combination of preventive measures in sub-Saharan Africa 
has reduced the rate of HIV mother to child transmission 
from 10.4% to 1.4%[2,3]. In Burkina Faso, the control program 
of HIV transmission from mother to child and sexually 
transmitted diseases was established 20 years ago. In 2008, 
the overall prevalence of HIV among women aged 15 to 49 
years was 2.0%[4]. Despite the introduction of antiretroviral 
treatment in the various protocols developed at national 
Objective: To evaluate efficiency of HAART in the prevention of mother to child HIV 
transmission. Methods: A longitudinal study was conducted on 1 300 women attending the 
antenatal service at Saint Camille Medical Centre from September 2010 to July 2011. The HIV 
status of mothers was determined by rapid tests and ELISA. Discordant results were confirmed 
by real-time PCR. PCR was used to determine HIV status of children born from HIV-positive 
mothers. Results: Among 1 300 pregnant women tested for HIV, 378 were seropositive. Mothers 
were predominantly housewives (69.7%), and their mean age was (28.32暲0.15) years. The overall 
prevalence of HIV transmission from mother to child was 4.8% (18/378). This prevalence differed 
significantly from 0.0% (0/114) to 6.8% (18/264) in children born from mothers under HAART 
and those with mothers under New Prophylactic Protocol (AZT + 3TC + NVP), respectively (P< 
0.01). Children’s mortality rate during the medical follow up was 1.3% (5/378). Among 16 women 
with HIV dubious status by ELISA, the Real Time PCR confirmed 2/16 (12.5%) as HIV positive. 
Conclusions: The protocol of prevention of mother to children HIV transmission (PMTCT) 
is effective. The rate of HIV vertical transmission is significantly reduced. Early diagnosis 
determined by PCR of children born from HIV- positive mother is necessary and recommended 
in the context of PMTCT in Burkina Faso. We also found that PCR is an effective tool to confirm 
HIV status in pregnant women.
Laure Stella Ghoma Linguissi et al./Asian Pacific Journal of Tropical Medicine (2012)991-994992
level, a residual risk of HIV transmission persists in infants 
born from HIV positive mothers.
  Early diagnosis and initiation of antiretroviral therapy 
among HIV-positive children are crucial to the reduction 
of morbidity and mortality among children born from HIV-
positive mothers[5]. PCR has proven to be an indispensable 
tool in early diagnosis of HIV among children born from 
seropositive mothers. Furthermore, the use of RT-PCR 
is necessary for the confirmation of undetermined ELISA 
tests in adults[6]. The purpose of this study was the early 
diagnosis of HIV-1 by PCR in children born from HIV-1 
seropositive women and the confirmation of pregnant women 
HIV infection status with equivocal ELISA by RT- Real Time 
PCR.  
2. Materials and methods
2.1. Study sites
  This prospective study was conducted at Saint Camille 
Medical Centre and at the Biomolecular Research Centre 
Pietro Annigoni, two reference centers in the management of 
HIV in Ouagadougou, Burkina Faso. Patients were recruited 
from September 2010 to July 2011. Clinical monitoring of 
HIV infected pregnant women has been done as well as the 
management of children born from HIV positive mothers. 
 
2.2. Patients and determination of pregnant women HIV 
status
  A total of 1 300 pregnant women with pregnancy under 
28 weeks were included for HIV testing. Venous blood was 
collected from them and dried blood spots samples were 
collected from 378 children born from HIV-positive mothers.
HIV screening of pregnant women was done by the rapid 
test determine (Determine HIV-1/2 test, Alere GmbH, Koln, 
United Kingdom) and SD-Bioline (SD BioLine HIV-1/2 
antibody testTM 3.0, Standard Diagnostics, Inc.), following 
the manufacturer’s instructions. A Sample was considered 
positive if reactive to the two rapid tests.
 
2.3. HIV-1 therapy
 During her last visit at the hospital before delivery, the 
future mother was given anti-retrovirals to prevent mother 
to child HIV transmission:
  Doses of AZT capsules of 300 mg, to be taken twice a day, 
from the 28th week until delivery;
  A unique dose of 200 mg nevirapine  twice a day; 
  Capsules of AZT/3TC 300 mg/150 mg (DUOVIR): the first dose 
was administered during labor and 7 days post-partum.
  After delivery, the newborn was taken into neonatology unit 
at Saint Camille Medical Center (if the delivery took place 
at Saint Camille maternity or a center that did not dispose 
of nevirapine and  AZT)  where he or she got one dose of 
nevirapine (2 mg/kg PU) and an AZT (4 mg twice per day).  
The newborn was then kept during three days at the 
neonatology unit if he or she was born at Saint Camille 
Medical Center. Furthermore, there was a follow up twice 
during the first month of birth, then once a month until the 
infant reached his or her first year. 
2.4. DNA extraction and detection of HIV by PCR in children
  DNA extraction was done with the Qiagen QIAmp kit 
(QIAGEN, Hilden, Germany) and PCR was performed using 
the kit Generic cell DNA (Biocentric, Bandol, France) with a 
9700 thermocycler (Applied Biosystems, USA), following the 
manufacturer’s instructions.
2.5. Detection of HIV-1 by qualitative RT-Real Time PCR
  HIV-1 RNA was detected in plasma samples using one 
step RT-Real Time PCR Kit (kit Real-TM Qual HIV, Sacace 
Biotechnology, Como, Italy) following the manufacturer’s 
instructions. RT-Real Time PCR was carried out in 7500 Fast 
Real Time PCR machine (Applied Biosystems, USA). The 
program of amplification was as follow: reverse transcription 
at 50 曟 for 30 min, a pre-amplification step of 95 曟 at 15 
min following by 45 cycles comprising 95 曟 for 20 sec; 55 曟 
for 40 sec and 72 曟 for 30 sec.
2.6. Statistical analysis
  Data analysis was done by Statistical Package for the Social 
Sciences (SPSS version 17.0) and Epi Info 6.4. The results 
were considered significant for P < 0.05.
2.7. Ethics
  The study was approved by the Joint Saint Camille/CERBA 
Ethics Committee. Individual informed consent was obtained 
from all pregnant women.
3. Results
3.1. Sociodemographic characteristics of mothers and 
children PCR results
  The average age of pregnant women was (28.32暲0.15) 
years. The majority of women belonged to the age group 26-
31 years (41.45%). The highest rates of HIV were found in 
pregnant women belonging to the category of homemakers 
(35.1%), informal sector (26.9%) and government workers 
(23.5%) (Table 1). Among the 1 300 pregnant women included 
in the study, 378 (29.08%) were tested positive for HIV-1. 
These pregnant women had regular medical monitoring 
prior to delivery and early diagnosis of HIV-1 by PCR was 
Laure Stella Ghoma Linguissi et al./Asian Pacific Journal of Tropical Medicine (2012)991-994 993
performed on their children.
Table 1
Sociodemographic characteristics of mothers and PCR results of their 
children.
Characteristics HIV-1 Serology PCR
P o s i t i v e 
women 
% P o s i t i v e 
children 
%
Age groups < 20 14/87 16.1   2/14 14.3
20-25   70/320 21.9   5/70   7.1
26-31 158/551 28.7   4/158   2.5
32-37 111/263 42.2   6/111   5.4
> 37   25/79 31.6   1/25   4.0
Profession Housemakers 264/767 34.4 15/264   5.7
Informal sector   82/312 26.3   3/82   3.7
School     9/119   7.6   0/9   0.0
G o v e r n m e n t 
workers
  23/102 22.5   0/23   0.0
  
3.2. Confirmation of pregnant women HIV status by RT-
real-time PCR and PCR 
  As shown in Table 2, pregnant women whose plasmas were 
reactive (5/25) or negative (4/25) to both rapid tests were 
all confirmed positive or negative by RT-Real Time PCR. 
However, among the 16 pregnant women with undetermined 
HIV-1 serology, 2/16 (12.5%) and 14/16 (87.5%) were 
confirmed positive and negative by RT-Real Time PCR, 
respectively. The status HIV-1-negative in pregnant women 
with equivocal serology was also confirmed by PCR. All the 
14 pregnant women HIV-1 negative by RT-Real Time PCR 
were confirmed negative by PCR.
Table 2
Pregnant women's serology confirmation by RT Real-Time PCR and 
PCR.
Group R a p i d 
tests
RT-real-time-PCR 
                  
PCR
Negative       Positive    Negative Positive
Undetermined 16/25 
(64.0%)
14/16 
(87.5%)
2/16 
(12.5%)
14/14 
(100.0%)
0/14 
(0.0%)
Negative 4/25
 (16.0%)
4/4 
(100.0%)
0/4 
(0.0%)
4/4
 (100.0%)
0/4 
(0.0%)
Positive 5/25
(20.0%)
0/5 
(0.0%)
5/5 
(100.0%)
- -
Total 25 18 7 18 0
3.3. Rate of HIV-1 mother to child transmission
  In this study 69.84% (264/378) of mothers was under the 
new prophylactic protocol (AZT + 3TC + NVP). At birth, their 
children have received a single dose of niverapine + AZT for 
4 weeks as prophylaxis. One hundred and fourteen pregnant 
women (114/378, 30.16%) were on HAART.
  The prevalence of HIV-1 by PCR was 0.00% (0/114) and 
6.82% (18/264) in children born from mothers under HAART 
and those under prophylaxis, respectively (P<0.01). A 
mortality of 1.32% (5/378) was observed in children born 
from HIV-positive mothers. This mortality was not related to 
breastfeeding.
4. Discussion
  Sub-Saharan Africa remains the part of the world where the 
prevalence of HIV/AIDS is the most important. The expansion 
of programs to prevent mother to child HIV transmission is 
hampered by economic and technical difficulties. Indeed, 
only seven countries including Argentina, Botswana, 
Brazil, Jamaica, Russia, Thailand and Ukraine have offered 
antiretroviral prophylaxis to more than 40% of HIV positive 
pregnant women[9-14]. With the exception of Botswana, all 
of those countries are outside sub-Saharan Africa, which is 
the most vulnerable region with more than 25 million AIDS 
patients[4].
  The socio-cultural prejudices and poverty make women 
and children more vulnerable to the AIDS pandemic. 
Previous studies conducted in Burkina Faso and Tanzania, 
have shown a vertical transmission rate of 6.82%[8] and an 
HIV prevalence of 14.5% in pregnant women[9]. Breastfeeding 
is responsible for 5% to 20% of mother to child HIV 
transmission[10]. 
  The main objective of this study was the use of molecular 
tools (conventional PCR and RT-Real Time PCR) in the 
diagnosis of HIV-1 infection in infants born from seropositive 
mothers and pregnant women with undetermined serology, 
respectively.
  The overall prevalence of HIV-1 was 4.8% among children 
born from HIV-positive mothers. This prevalence is lower 
than 10.4% and 9.2% reported by Simpore et al[2] in children 
aged 5 to 6 months and in the study of Deschamps et al[11], 
respectively.
  HIV-1 Transmission was significantly reduced in children 
born from HIV-positive mothers under HAART compared 
with those whose mothers were under prophylaxis.  
  Breastfeeding is responsible for 5% to 20% of HIV mother 
to child transmission[10]. We found that the prevalence of 
HIV-1 were 6.52% and 4.20% respectively in children under 
breastfeeding and artificial feeding; the difference was not 
significant. This is consistent with the study of Simpore et 
al[2] where the prevalence of HIV-1 was similar in children 
under breastfeeding and those under artificial feeding (9.4% 
versus 10.7%). 
  The mortality rate of children during the study period 
was 1.32%. This mortality was not related to type of feeding 
received by childre[14-20]. Previous studies conducted at 
Saint Camille Medical Center have shown that the protocol 
of mother to child HIV transmission, based on the mono 
prophylaxie  using nevirapine had significantly reduced the 
rate of HIV transmission to 10.36%[2] and 9.09%[8]. Previous 
results have described a higher rate of residual transmission 
with nevirapine treatment 15.0%[12].
  Among the women in our study who were under the new 
protocol prophylactic AZT +3 TC + NVP, the rate of vertical 
transmission was 6.82% (18/264) while that of the study of 
Sagna et al[8] reported 4.55%. A longitudinal study (2000 to 
2006) of 30 854 pregnant women showed an HIV prevalence 
of 0.44% and a vertical transmission rate of 9.7%[21].
  We have demonstrated the feasibility of using Real Time-
PCR to confirm the HIV-1 indeterminate serology by ELISA. 
Indeed, on 16 pregnant women with an indeterminate 
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serology, two were confirmed positive by Real Time PCR. 
In the study of Nagalo et al[6], the strategy to test only the 
samples whose status is indeterminate via HIV ELISA, 
resulted in a fast confirmation of the mother’s serology 
status, which is necessary for their clinical management. 
However, the lack of financial resources can be an obstacle 
to the extension of the PCR which currently is only reserved 
for the early diagnosis of HIV infection in children.
  This study shows the effectiveness of HAART in the 
protection of mother to child HIV transmission. The PCR 
using proviral DNA allows earlier diagnosis of HIV-1 
infection in children. The real-time PCR is a useful tool 
for confirmation of doubtful serology in HIV-1. These 
results may contribute to the popularization of PCR in early 
diagnosis in children born from seropositive mothers.
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